The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Posey, D. J.
* Articles by McDougle, C. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Posey, D. J.
* Articles by McDougle, C. J.
Related Collections
* Child/Adolescent Psychiatry
* Autism
Am J Psychiatry 161:2115-2117, November 2004
© 2004 American Psychiatric Association


Brief Report

A Pilot Study of D-Cycloserine in Subjects With Autistic Disorder

David J. Posey, M.D., Deborah L. Kem, B.A., Naomi B. Swiezy, Ph.D., Thayne L. Sweeten, Ph.D., Ryan E. Wiegand, M.S., and Christopher J. McDougle, M.D.

OBJECTIVE: The authors assessed the effects of D-cycloserine on the core symptom of social impairment in subjects with autism. METHOD: Following a 2-week, single-blind placebo lead-in phase, drug-free subjects with autistic disorder were administered three different doses of D-cycloserine during each of three 2-week periods. Measures used for subject ratings included the Clinical Global Impression (CGI) scale and Aberrant Behavior Checklist. RESULTS: Significant improvement was found on the CGI and social withdrawal subscale of the Aberrant Behavior Checklist. D-Cycloserine was well tolerated at most of the doses used in this study. CONCLUSIONS: In this pilot study, D-cycloserine treatment resulted in significant improvement in social withdrawal. Further controlled studies of D-cycloserine in autism appear warranted.




This article has been cited by other articles:


Home page
J Child NeurolHome page
M. G. Chez, Q. Burton, T. Dowling, M. Chang, P. Khanna, and C. Kramer
Memantine as Adjunctive Therapy in Children Diagnosed With Autistic Spectrum Disorders: An Observation of Initial Clinical Response and Maintenance Tolerability
J Child Neurol, May 1, 2007; 22(5): 574 - 579.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
Y. Liu, T. P. Wong, M. Aarts, A. Rooyakkers, L. Liu, T. W. Lai, D. C. Wu, J. Lu, M. Tymianski, A. M. Craig, et al.
NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo
J. Neurosci., March 14, 2007; 27(11): 2846 - 2857.
[Abstract] [Full Text] [PDF]


Home page
AutismHome page
C. Woodard, J. Groden, M. Goodwin, and J. Bodfish
A placebo double-blind pilot study of dextromethorphan for problematic behaviors in children with autism
Autism, January 1, 2007; 11(1): 29 - 41.
[Abstract] [PDF]


Home page
Psychiatr. NewsHome page
J. Arehart-Treichel
Antibiotic Offers Some Hope In Autism Treatment
Psychiatr News, December 3, 2004; 39(23): 25 - 25.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org